Andrew Mok
Stock Analyst at Barclays
(2.59)
# 2,052
Out of 4,826 analysts
165
Total ratings
51.28%
Success rate
-1.87%
Average return
Main Sectors:
Stocks Rated by Andrew Mok
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Overweight | $73 → $82 | $67.46 | +21.55% | 8 | May 2, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $161 → $171 | $148.03 | +15.52% | 12 | Apr 30, 2025 | |
| UHS Universal Health Services | Maintains: Overweight | $249 → $257 | $178.74 | +43.78% | 22 | Apr 29, 2025 | |
| EHC Encompass Health | Maintains: Buy | $117 → $130 | $116.64 | +11.45% | 16 | Apr 28, 2025 | |
| CNC Centene | Maintains: Overweight | $93 → $84 | $60.16 | +39.63% | 7 | Apr 28, 2025 | |
| MOH Molina Healthcare | Maintains: Equal-Weight | $339 → $362 | $318.04 | +13.82% | 5 | Apr 25, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $560 → $513 | $399.92 | +28.28% | 8 | Apr 24, 2025 | |
| ELV Elevance Health | Maintains: Overweight | $512 → $522 | $409.98 | +27.32% | 7 | Apr 23, 2025 | |
| HUM Humana | Maintains: Equal-Weight | $270 → $322 | $258.48 | +24.57% | 8 | Apr 11, 2025 | |
| PRVA Privia Health Group | Maintains: Equal-Weight | $21 → $23 | $23.30 | -1.29% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $36 | $32.49 | +10.80% | 1 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $74 → $60 | $53.38 | +12.40% | 7 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $43 → $35 | $23.31 | +50.18% | 12 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $8 → $9 | $15.53 | -42.05% | 4 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $5 → $4 | $2.83 | +41.34% | 5 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $164 → $169 | $141.13 | +19.75% | 10 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $339 | $334.75 | +1.27% | 4 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $392 → $366 | $347.97 | +5.18% | 9 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $5 → $2 | $4.16 | -51.92% | 2 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $88 → $83 | $105.00 | -20.95% | 2 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $35 | $23.08 | +51.65% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $12 | $8.05 | +49.07% | 1 | Dec 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $145 → $95 | $95.94 | -0.98% | 7 | Aug 2, 2022 |
CVS Health
May 2, 2025
Maintains: Overweight
Price Target: $73 → $82
Current: $67.46
Upside: +21.55%
Tenet Healthcare
Apr 30, 2025
Maintains: Overweight
Price Target: $161 → $171
Current: $148.03
Upside: +15.52%
Universal Health Services
Apr 29, 2025
Maintains: Overweight
Price Target: $249 → $257
Current: $178.74
Upside: +43.78%
Encompass Health
Apr 28, 2025
Maintains: Buy
Price Target: $117 → $130
Current: $116.64
Upside: +11.45%
Centene
Apr 28, 2025
Maintains: Overweight
Price Target: $93 → $84
Current: $60.16
Upside: +39.63%
Molina Healthcare
Apr 25, 2025
Maintains: Equal-Weight
Price Target: $339 → $362
Current: $318.04
Upside: +13.82%
UnitedHealth Group
Apr 24, 2025
Maintains: Overweight
Price Target: $560 → $513
Current: $399.92
Upside: +28.28%
Elevance Health
Apr 23, 2025
Maintains: Overweight
Price Target: $512 → $522
Current: $409.98
Upside: +27.32%
Humana
Apr 11, 2025
Maintains: Equal-Weight
Price Target: $270 → $322
Current: $258.48
Upside: +24.57%
Privia Health Group
Apr 10, 2025
Maintains: Equal-Weight
Price Target: $21 → $23
Current: $23.30
Upside: -1.29%
Apr 1, 2025
Initiates: Equal-Weight
Price Target: $36
Current: $32.49
Upside: +10.80%
Mar 24, 2025
Maintains: Overweight
Price Target: $74 → $60
Current: $53.38
Upside: +12.40%
Feb 28, 2025
Downgrades: Equal-Weight
Price Target: $43 → $35
Current: $23.31
Upside: +50.18%
Feb 28, 2025
Maintains: Underweight
Price Target: $8 → $9
Current: $15.53
Upside: -42.05%
Feb 20, 2025
Maintains: Equal-Weight
Price Target: $5 → $4
Current: $2.83
Upside: +41.34%
Feb 18, 2025
Maintains: Equal-Weight
Price Target: $164 → $169
Current: $141.13
Upside: +19.75%
Jan 31, 2025
Maintains: Overweight
Price Target: $420 → $339
Current: $334.75
Upside: +1.27%
Jan 27, 2025
Maintains: Overweight
Price Target: $392 → $366
Current: $347.97
Upside: +5.18%
Nov 11, 2024
Maintains: Underweight
Price Target: $5 → $2
Current: $4.16
Upside: -51.92%
Apr 23, 2024
Downgrades: Underweight
Price Target: $88 → $83
Current: $105.00
Upside: -20.95%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $35
Current: $23.08
Upside: +51.65%
Dec 8, 2022
Initiates: Sell
Price Target: $12
Current: $8.05
Upside: +49.07%
Aug 2, 2022
Downgrades: Sell
Price Target: $145 → $95
Current: $95.94
Upside: -0.98%